Comparative Pharmacology
Head-to-head clinical analysis: DERMATOP E EMOLLIENT versus TOPICORT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DERMATOP E EMOLLIENT versus TOPICORT.
DERMATOP E EMOLLIENT vs TOPICORT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prednicarbate is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of phospholipase A2, decreased release of arachidonic acid, and reduced synthesis of prostaglandins, leukotrienes, and other inflammatory mediators.
Topical corticosteroid that induces phospholipase A2 inhibitory proteins, collectively called lipocortins, which inhibit the release of arachidonic acid, thereby reducing production of prostaglandins and leukotrienes, leading to anti-inflammatory, antipruritic, and vasoconstrictive effects.
Apply a thin layer topically to affected areas twice daily. Maximum 3-week course.
Apply a thin film to the affected skin areas twice daily. Maximum adult dose: 50 g/week. Not for use on the face, axillae, or groin. Do not use under occlusive dressings.
None Documented
None Documented
Terminal elimination half-life: 18-36 hours. Clinically, once-daily dosing maintains therapeutic effect.
Terminal elimination half-life: 2-4 hours for parent drug; clinical effect lasts longer due to receptor binding
Predominantly hepatic metabolism; renal excretion of metabolites <5% unchanged; biliary/fecal excretion minimal.
Renal (metabolites): ~75%; Fecal: ~25%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid